MedCity News January 22, 2026
There must be clear rules and regulations in effect if we are to see medical-grade CBD become widely accepted amongst clinicians.
The funding bill passed in November by Congress did much more than end an historic government shutdown – it also paved the way for sweeping changes that, if implemented as planned, will impact the hemp and cannabis markets. As of right now, in November of 2026, products with even a small amount of tetrahydrocannabinol (THC) – as low as 0.4 mg of delta-9 THC – will be banned. Currently, hemp is defined as a product containing less than 0.3% delta-9 THC.
Many opponents of this ban believe it will be the death of the hemp industry, significantly disrupting...
Today's Sponsors
Today's Sponsor